Portfolio, Program, and Project Management in the Pharmaceutical and Biotechnology Industries

by Pete Harpum (Editor)

Overview

This book describes the way that pharmaceutical projects and programs are currently managed, and offers views from many highly experienced practitioners from within the industry on future directions for drug program management. The book integrates portfolio, program, and project management processes as fundamental for effective and efficient drug product development. Contributing expert authors provide their view of how the projectization approach can be taken forward by the drug industry over the coming years.

Product Details

ISBN-13:	9780470049662
Publisher:	Wiley
Publication date:	04/05/2010
Pages:	352
Product dimensions:	6.30(w) x 9.30(h) x 1.00(d)

About the Author

PETE HARPUM is a Director of Harpum Consulting and has been consulting on Portfolio, Program, and Project Management (P³M) for some ten years. He chairs and contributes to many conferences and symposiums on P³M. Mr. Harpum's other activities include postgraduate lecturing and research on P³M for three world-class universities, and supporting the Association for Project Management, Project Management Institute, and the Drug Information Association in various ways.

Read an Excerpt

Click to read or download

Table of Contents

Preface ix

Acknowledgments xi

About the Authors xiii

Part 1 The Life Science Industry Context for Portfolio, Program, and Project Management

1 A Review of Project Management in Life Science Industry Sectors Thomas R. Dunson 3

2 The Impact of Organizational Size on Drug Project Management Eric Morfin 21

3 Drug Development in Biotechnology and How We Can Do It Better Susan Linna 33

Part 2 The Portfolio, Program, and Project Management Approaches and Processes

4 An Overview of the Organization and Processes of Portfolio, Program, and Project Management Pete Harpum 53

5 Portfolio Management in the Pharmaceutical Industry: Balancing Corporate Need with the Reality of Delivering Products to the Market John Bennett 59

6 Program Management in Drug Development Pauline Stewart-Long 85

7 Project Control Martin Powell 101

8 Managing Uncertainty in Drug Projects Pete Harpum Thomas R. Dunson 135

9 Managing Drug Safety Risk Thomas R. Dunson Eric Morfin 155

10 Developing Program Strategy Pete Harpum 175

11 Developing Products with "Added Value" Trevor J. Brown Stephen Allport 197

Part 3 Integrating the Processes

12 Integrated Business Processes to Support Cross-Functional Drug Development Martin D. Hynes III 227

13 Integrated Drug Development From Gradle to Grave and from Lab to Market Stephen Allport Terry Cooke-Davies 239

14 The Development of P³M Capability in Drug Development Organizations John Arrowsmith Patrick Grogan Bob Moore 259

15 Implementing Portfolio, Program, and Project Management Best Practices in Drug Development Organizations Pete Harpum Ashley Jamieson Inge Fisher 287

Bibliography 311

Index 313